公司概覽
業務類別 Diagnostics & Research
業務概覽 In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
公司地址 2200 Pennsylvania Avenue, NW, Suite 800W, Washington, DC, USA, 20037-1701
電話號碼 +1 202 828-0850
傳真號碼 +1 202 828-0860
公司網頁 https://www.danaher.com
員工數量 60000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Rainer M. Blair Director, President and Chief Executive Officer 美元 1.35M 24/02/2026
Mr. Gregory M. Milosevich Executive Vice President -- 24/02/2026
Mr. Jonathan B. Leiken Senior Vice President and Chief Legal Officer -- 24/02/2026
Mr. Matthew E. Gugino Executive Vice President and Chief Financial Officer -- 24/07/2025
Mr. Christopher M. Bouda Vice President and Chief Accounting Officer -- 24/02/2026
Ms. Georgeann F. Couchara Senior Vice President, Human Resources 美元 726.00K 24/02/2026
Mr. Christopher Paul Riley Executive Vice President -- 24/02/2026
Mr. Matthew R. McGrew Executive Vice President 美元 990.47K 24/07/2025
Dr. Jose-Carlos Gutierrez-Ramos, PhD Senior Vice President and Chief Science Officer 美元 862.58K 24/02/2026
Mr. R. Bradley Gray Senior Vice President, Strategic Development -- 24/02/2026
Ms. Julie A. Sawyer Montgomery Executive Vice President -- 24/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Rainer M. Blair Director, President and Chief Executive Officer 24/02/2026
Mr. John T. Schwieters Independent Director 24/02/2026
Mr. Feroz Dewan Independent Director 24/02/2026
Mr. Mitchell P. Rales Director 24/02/2026
Ms. Linda Hefner Filler Lead Independent Director 24/02/2026
Ms. Teri L. List-Stoll Independent Director 24/02/2026
Mr. Alan G. Spoon, J.D. Independent Director 24/02/2026
Mr. Charles W. Lamanna Independent Director 24/02/2026
Mr. Steven M. Rales Chairman of the Board 24/02/2026
Mr. A. Shane Sanders Independent Director 24/02/2026
Professor Raymond C. Stevens, PhD Independent Director 24/02/2026
Dr. Elias A. Zerhouni, M.D. Independent Director 24/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:49)
代號 名稱 佔比% 持有日期
IYHiShares US Healthcare ETF0.05%28/02/2026
VONVVanguard Russell 1000 Value ETF0.05%31/01/2026
IXJiShares Global Healthcare ETF0.05%28/02/2026
DGROiShares Core Dividend Growth ETF0.04%28/02/2026
DFUVDimensional US Marketwide Value ETF0.04%27/02/2026
FHLCFidelity MSCI Health Care ETF0.04%28/02/2026
CGGRCapital Group Growth ETF0.03%31/01/2026
FNDXSchwab Fundamental U.S. Large CompanyETF0.03%28/02/2026
DFUSDimensional US Equity Market ETF0.03%27/02/2026
ACWIiShares MSCI ACWI ETF0.03%28/02/2026
DFACDimensional US Core Equity 2 ETF0.02%27/02/2026
IWViShares Russell 3000 ETF0.02%28/02/2026
NULVNuveen ESG Large-Cap Value ETF0.02%27/02/2026
THQabrdn Healthcare Opportunities0.02%31/01/2026
VOOVVanguard S&P 500 Value ETF0.02%31/01/2026
ESGVVanguard ESG US Stock ETF0.02%31/01/2026
MGCVanguard Mega Cap ETF0.02%31/01/2026
XTiShares Future Exponential Techs ETF0.02%28/02/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.02%27/02/2026
EXGEV Tax-Mgd Gbl Div Equity Income0.02%31/12/2025
  1   2    3    4    5    6    7    8    9    10    11    12    13    14    15    16  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.